Bioniz, LLC
Records under this name other than patents Bioniz, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,133,243 | Compositions and Methods for Modulating Gamma-C-Cytokine Activity Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,133,244 | Compositions and Methods for Modulating Gamma-C-Cytokine Activity Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,951,105 | Methods of Developing Selective Peptide Antagonists Formerly held In force · Low confidence | In force | Low confidence | |
| US 10,227,382 | Method of Designing a Peptide And/Or Peptide Derivative for Modulating Gamma-C-Cytokine Activity Formerly held In force · Low confidence | In force | Low confidence | |
| US 10,808,009 | Peptide Conjugates Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,708,392 | Peptide Conjugates Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,834,519 | Compositions and Methods for Modulating Gamma-C-Cytokine Activity Formerly held In force · Low confidence | In force | Low confidence | |
| US 9,959,384 | Methods of developing selective peptide antagonists Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,854,312 | Selective peptide antagonists Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,462,297 | Selective Peptide Antagonists Formerly held In force · Medium confidence | In force | Medium confidence |